This special report gives you the opportunity to gain a broader understanding of CBD in the Nordic countries by combining individual regulatory reports for Sweden, Norway, Denmark and Finland. Each report provides a detailed overview of the regulatory regime for hemp, CBD and cannabis in each country and covers all areas of the framework including extracts, finished products, import/export requirements, and medical and recreational cannabis.
Norway has a fairly strict regime when it comes to CBD and cannabis - with both falling under the same regulatory framework - and in Denmark CBD is considered a pharmaceutical substance, while it is not a scheduled substance in either Sweden or Finland.
The benefit of this bundle is that it enables a comparative analysis of these four countries, allowing you to draw similarities and differences between the regimes. Despite being so close to one another, each country has a fairly different approach to regulation, and so if you are interested in the Scandinavian market, then this report provides you with a comprehensive overview of each market.
Table of Contents
Companies Mentioned
- Kanavape
- The Green Party
- Finola
- Kanavape
Methodology
General Methodology/Sources
- Consumer and market participant (manufacturer/brand) surveys.
- Consolidation of publicly available information.
- Legal tracking through legal database checking and sourcing information from government regulators and other law-making bodies.
- Pricing and product information from online and offline retail data gathering, including local fieldwork teams.
- Findings from key industry events and interviews with leading market players and opinion leaders.
- Partnerships with leading research agencies.
- Quantitative and qualitative research and client collaborations.
- Cross-referenced data between markets.
- Tamarind Media proprietary market model.
Please note that each report has its own methodology, so you should always refer to the methodology applied in the report you purchase.
LOADING...
